Association between prescription of major psychotropic medications and violent reoffending after prison release

JAMA - Journal of the American Medical Association

Volumn 316, Issue 17, 2016, Pages 1798-1807

  Chang, Zheng ^a,b   Lichtenstein, Paul ^a   Langström, Niklas ^a,c   Larsson, Henrik ^a,d   Fazel, Seena ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b WARNEFORD HOSPITAL   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

^d ÖREBRO UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COHORT ANALYSIS; CRIME; DRUG DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PRISONER; RISK FACTOR; SCHIZOPHRENIA; SWEDEN; VIOLENCE; AFTERCARE; FEMALE; MIDDLE AGED; PSYCHOTHERAPY; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ADOLESCENT; ADULT; AFTERCARE; COHORT STUDIES; CRIME; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PRISONERS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; SWEDEN; VIOLENCE;

EID: 84997109166     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.15380     Document Type: Article

References (39)

1. Walmsley R.World prison population list, 11th ed. http://www.prisonstudies.org/sites/default/files/resources/downloads/world-prison-population-list-11th-edition.pdf. Accessed July 2, 2016.
2. Durose MR, Cooper AD, Snyder HN. Recidivism of prisoners released in 30 states in 2005: patterns from 2005 to 2010. http://www.bjs.gov/content/pub/pdf/rprts05p0510.pdf. Accessed April 21, 2015.
3. Ministry of Justice. Compendium of reoffending statistics and analysis 2012. https://www.gov.uk/government/statistics/compendium-of-reoffending-statistics-and-analysis. Accessed April 21, 2015.
4. Lamb HR,Weinberger LE. Decarceration of US jails and prisons: where will persons with serious mental illness go J AmAcad Psychiatry Law. 2014; 42(4):489-494.
5. McGuire J. A review of effective interventions for reducing aggression and violence. Philos Trans R Soc Lond B Biol Sci. 2008;363(1503):2577-2597.
6. Chang Z, Larsson H, Lichtenstein P, Fazel S. Psychiatric disorders and violent reoffending: a national cohort study of convicted prisoners in Sweden. Lancet Psychiatry. 2015;2(10):891-900.
7. Fazel S, Seewald K. Severe mental illness in 33,588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry. 2012; 200(5):364-373.
8. Leucht S, Tardy M, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379(9831):2063-2071.
9. Fazel S, Zetterqvist J, Larsson H, Långström N, Lichtenstein P. Antipsychotics, mood stabilisers, and risk of violent crime. Lancet. 2014;384(9949): 1206-1214.
10. Lichtenstein P, Halldner L, Zetterqvist J, et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med. 2012;367 (21):2006-2014.
11. FrankleW, Shera D, Berger-Hershkowitz H, et al. Clozapine-associated reduction in arrest rates of psychotic patients with criminal histories. Am J Psychiatry. 2001;158(2):270-274.
12. Dailey LF, TownsendSW,DyskenMW, Kuskowski MA. Recidivism in medication-noncompliant serious juvenile offenders with bipolar disorder. J Clin Psychiatry. 2005;66(4):477-484.
13. McMurran M. What works in substance misuse treatments for offenders Crim Behav Ment Health. 2007;17(4):225-233.
14. Gibbons RD, Amatya AK, Brown CH, et al. Post-approval drug safety surveillance. Annu Rev Public Health. 2010;31:419-437.
15. Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):47-56.
16. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659-667.
17. Kriminalvården. The Swedish Prison and Probation Service website. https://www .kriminalvarden.se/. Accessed April 21, 2015.
18. Wettermark B,HammarN, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726-735.
19. Kriminalvården. Behandlingsprogram. http://www.kriminalvarden.se/behandling-och-vard/behandlingsprogram. Accessed October 30, 2014.
20. Andrews DA, Bonta J. The Psychology of Criminal Conduct. 5th ed. London, England: Routledge; 2010.
21. Correctional Service Canada. Offender rehabilitation: correctional programs. http://www .csc-scc.gc.ca/correctional-process/002001-2001-eng.shtml. Accessed October 30, 2014.
22. National Council for Crime Prevention. Kriminalstatistik 2010. Västerås, Sweden: National Council for Crime Prevention; 2011.
23. Chang Z, Lichtenstein P, D'Onofrio BM, Sjölander A, Larsson H. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 2014;71 (3):319-325.
24. Webb RT, Lichtenstein P, Larsson H, Geddes JR, Fazel S. Suicide, hospital-presenting suicide attempts, and criminality in bipolar disorder: examination of risk for multiple adverse outcomes. J Clin Psychiatry. 2014;75(8):e809-e816.
25. Fazel S, Långström N, Hjern A, Grann M, Lichtenstein P. Schizophrenia, substance abuse, and violent crime. JAMA. 2009;301(19):2016-2023.
26. Skeem JL, Manchak S, Peterson JK. Correctional policy for offenders with mental illness: creating a new paradigm for recidivism reduction. Law Hum Behav. 2011;35(2):110-126.
27. Coid JW, Ullrich S, Kallis C, et al. The relationship between delusions and violence: findings from the East London First Episode Psychosis Study. JAMA Psychiatry. 2013;70 (5):465-471.
28. Keers R, Ullrich S, Destavola BL, Coid JW. Association of violence with emergence of persecutory delusions in untreated schizophrenia. Am J Psychiatry. 2014;171(3):332-339.
29. Chang Z, Lichtenstein P, Asherson PJ, Larsson H. Developmental twin study of attention problems: high heritabilities throughout development. JAMA Psychiatry. 2013;70(3):311-318.
30. Polanczyk G, Rohde LA. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Curr Opin Psychiatry. 2007;20(4):386-392.
31. Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3):PCC.13r01600.
32. Pearson FS, Lipton DS. Ameta-analytic review of the effectiveness of corrections-based treatments for drug abuse. Prison J. 1999;79(4): 384-410. doi:10.1177/0032885599079004003
33. Mitchell O, Wilson DB, MacKenzie DL. Does incarceration-based drug treatment reduce recidivism ameta-analytic synthesis of the research. J Exp Criminol. 2007;3(4):353-375. doi:10.1007/s11292-007-9040-2
34. Rich JD, McKenzie M, Larney S, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386 (9991):350-359.
35. Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction. 2006;101(2):181-191.
36. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison-a high risk of death for former inmates. N Engl J Med. 2007;356(2):157-165.
37. Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183-190.
38. Brennan PA, Mednick SA, Hodgins S. Major mental disorders and criminal violence in a Danish birth cohort. Arch Gen Psychiatry. 2000;57(5):494-500.
39. Huhn M, Tardy M, Spineli LM, et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry. 2014;71(6):706-715.